Eventide Asset Management, Llc Buys Prometheus Biosciences Inc, Prometheus Biosciences Inc, Entegris Inc, Sells Ecolab Inc, Eidos Therapeutics Inc, Sarepta Therapeutics Inc

• New Purchases: RXDX, RXDX, CGEM, ZYME, BBIO, BYND, BFLY, CRDF, PHVS, BCYC, SNV, SGFY, ELS, SLDB, OLK, PAYC,
• Added Positions: ENTG, TSM, TRIL, GNRC, DHI, IMVT, BEPC, CTAS, VITL, KURA, BHVN, ARGX, NBIX, ETNB, CCXI, XENE, KRTX, STE, CCI, FRC, KROS, VFC, PNR, CLDX, MGA, ODFL, IEX, A, KLAC, GRMN, PLD, SBNY, SNPS, ZI, FHN, AWK, MSCI, ROP, TT, EPIX, ARE, CIEN, CWEN, SYY, SNDX, LSCC, ZTS, FOUR, SBAC, RNG, NDAQ, NEP, AMD, VRSK, SLAB, MPWR, OM,
• Reduced Positions: SRPT, W, CRWD, VCYT, TPTX, HASI, PLRX, KALV, ADCT, SWKS, JKHY, CRNX, NXPI, SHW, LOW, DT, FENC, ETTX,
• Sold Out: ECL, EIDX, GWPH, LGVW, SGEN, AVRO, REGN, DCPH, MKC, ABCL, GLPG, ITT, MGTA, KNTE, AMWL, EQIX, DPZ,

For the details of EVENTIDE ASSET MANAGEMENT, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/eventide+asset+management%2C+llc/current-portfolio/portfolio

1. Exact Sciences Corp (EXAS) - 1,740,000 shares, 3.51% of the total portfolio.
2. Ascendis Pharma A/S (ASND) - 1,698,648 shares, 3.35% of the total portfolio. Shares reduced by 0.32%
3. Five9 Inc (FIVN) - 1,178,742 shares, 2.82% of the total portfolio. Shares added by 0.81%
4. The Trade Desk Inc (TTD) - 274,325 shares, 2.73% of the total portfolio. Shares added by 0.96%
5. CrowdStrike Holdings Inc (CRWD) - 891,285 shares, 2.49% of the total portfolio. Shares reduced by 11.07%

Eventide Asset Management, Llc initiated holding in Prometheus Biosciences Inc. The purchase prices were between $16.51 and $25.29, with an estimated average price of $20.65. The stock is now traded at around $16.820000. The impact to a portfolio due to this purchase was 1%. The holding were 3,714,032 shares as of 2021-03-31.

Eventide Asset Management, Llc initiated holding in Prometheus Biosciences Inc. The purchase prices were between $16.51 and $25.29, with an estimated average price of $20.65. The stock is now traded at around $16.820000. The impact to a portfolio due to this purchase was 1%. The holding were 3,714,032 shares as of 2021-03-31.

Eventide Asset Management, Llc initiated holding in Cullinan Oncology Inc. The purchase prices were between $28 and $53.42, with an estimated average price of $40.59. The stock is now traded at around $27.660000. The impact to a portfolio due to this purchase was 0.75%. The holding were 1,212,555 shares as of 2021-03-31.

Eventide Asset Management, Llc initiated holding in Zymeworks Inc. The purchase prices were between $29.83 and $56.81, with an estimated average price of $40.65. The stock is now traded at around $28.590000. The impact to a portfolio due to this purchase was 0.68%. The holding were 1,397,954 shares as of 2021-03-31.

Eventide Asset Management, Llc initiated holding in BridgeBio Pharma Inc. The purchase prices were between $55.47 and $72.35, with an estimated average price of $65.45. The stock is now traded at around $53.660000. The impact to a portfolio due to this purchase was 0.67%. The holding were 712,197 shares as of 2021-03-31.

Eventide Asset Management, Llc initiated holding in Beyond Meat Inc. The purchase prices were between $116.64 and $192.08, with an estimated average price of $147.49. The stock is now traded at around $104.970000. The impact to a portfolio due to this purchase was 0.3%. The holding were 152,593 shares as of 2021-03-31.

Eventide Asset Management, Llc added to a holding in Entegris Inc by 693.65%. The purchase prices were between $93.99 and $113.56, with an estimated average price of $102.97. The stock is now traded at around $109.450000. The impact to a portfolio due to this purchase was 0.92%. The holding were 616,099 shares as of 2021-03-31.

Eventide Asset Management, Llc added to a holding in Taiwan Semiconductor Manufacturing Co Ltd by 1656.20%. The purchase prices were between $108.96 and $140.05, with an estimated average price of $124.1. The stock is now traded at around $112.460000. The impact to a portfolio due to this purchase was 0.77%. The holding were 453,100 shares as of 2021-03-31.

Eventide Asset Management, Llc added to a holding in Trillium Therapeutics Inc by 60.18%. The purchase prices were between $9.86 and $15.51, with an estimated average price of $12.38. The stock is now traded at around $8.645000. The impact to a portfolio due to this purchase was 0.47%. The holding were 7,659,000 shares as of 2021-03-31.

Eventide Asset Management, Llc added to a holding in Generac Holdings Inc by 60.28%. The purchase prices were between $224.56 and $363.47, with an estimated average price of $295.22. The stock is now traded at around $300.890000. The impact to a portfolio due to this purchase was 0.43%. The holding were 229,200 shares as of 2021-03-31.

Eventide Asset Management, Llc added to a holding in D.R. Horton Inc by 39.89%. The purchase prices were between $65.85 and $89.85, with an estimated average price of $78.32. The stock is now traded at around $96.290000. The impact to a portfolio due to this purchase was 0.41%. The holding were 1,062,893 shares as of 2021-03-31.

Eventide Asset Management, Llc added to a holding in Immunovant Inc by 165.34%. The purchase prices were between $13.08 and $49.6, with an estimated average price of $26.3. The stock is now traded at around $15.500000. The impact to a portfolio due to this purchase was 0.38%. The holding were 2,473,000 shares as of 2021-03-31.

Eventide Asset Management, Llc sold out a holding in Ecolab Inc. The sale prices were between $204.51 and $225.74, with an estimated average price of $212.88.

Eventide Asset Management, Llc sold out a holding in Eidos Therapeutics Inc. The sale prices were between $117.32 and $128.51, with an estimated average price of $123.33.

Eventide Asset Management, Llc sold out a holding in GW Pharmaceuticals PLC. The sale prices were between $115.21 and $218.25, with an estimated average price of $188.36.

Eventide Asset Management, Llc sold out a holding in Longview Acquisition Corp. The sale prices were between $17.17 and $24, with an estimated average price of $20.43.

Eventide Asset Management, Llc sold out a holding in Seagen Inc. The sale prices were between $137.51 and $190.8, with an estimated average price of $161.21.

Eventide Asset Management, Llc sold out a holding in Avrobio Inc. The sale prices were between $10.54 and $19.3, with an estimated average price of $13.6.